Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation-Reference-Cited by-同舟云学术

Placebo Response in Pediatric Anxiety Disorders: Implications for Clinical Trial Design and Interpretation

Published:2016-10 Issue:8 Volume:26 Page:686-693
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Dobson Eric T.¹,Strawn Jeffrey R.¹²

Affiliation:

1. Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, College of Medicine, Cincinnati, Ohio.

2. Division of Child and Adolescent Psychiatry, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2015.0192

Reference43 articles.

1. American Psychiatric Association: Diagnostic and Statistical Manual for Mental Disorders, 4th ed. (DSM-IV). Washington, DC: American Psychiatric Association; 1994.

2. Incidence and Risk Patterns of Anxiety and Depressive Disorders and Categorization of Generalized Anxiety Disorder

3. SET-C Versus Fluoxetine in the Treatment of Childhood Social Phobia

4. School Phobia: A Therapeutic Trial with Clomipramine and Short-Term Outcome

5. Fluoxetine for the Treatment of Childhood Anxiety Disorders

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Impact of Development on Antidepressant and Placebo Response in Anxiety Disorders: A Bayesian Hierarchical Meta-Analytic Examination of Randomized Controlled Trials in Children, Adolescents, and Adults;Journal of Child and Adolescent Psychopharmacology;2024-05-27

2. Trajectory and magnitude of response in adults with anxiety disorders: a Bayesian hierarchical modeling meta-analysis of selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and benzodiazepines;CNS Spectrums;2024-03-25

3. Response to Plöderl et al. re: “A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder”;Journal of Child and Adolescent Psychopharmacology;2024-03-01

4. The current state-of-the-art in pharmacotherapy for pediatric generalized anxiety disorder;Expert Opinion on Pharmacotherapy;2023-04-19

5. Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder;Neuropsychopharmacology;2023-04-12